About

Edmund P. Harrigan, M.D., has served as an ACADIA director since November 2015. He is Principal at Harrigan Consulting and previously served as Senior Vice President of Worldwide Safety and Regulatory at Pfizer (2012-2015), among other senior Pfizer leadership roles spanning worldwide business development, regulatory affairs and neuroscience. He currently serves on the board of Incyte Corporation. He earned a B.A. in chemistry from St. Anselm College and an M.D. from the University of Massachusetts at Worcester.

Roles

Acadia Pharmaceuticals Inc.
Director · Current role
November 2015–present
Harrigan Consulting, LLC
Principal
July 2015 - present
Pfizer Inc.
Senior Vice President, Worldwide Safety and Regulatory
2012 - 2015
Pfizer Inc.
Senior Vice President, Head of Worldwide Business Development
—
Pfizer Inc.
Vice President, Head of Neuroscience and Ophthalmology
—

External Roles

Incyte Corporation
Director
—
Modulo Inc.
Director
—

Director Compensation

FY 2025
Fees earned or paid in cash
$41,928
ComponentAnnual Board and committee cash retainers earned in FY2025
Option awards
$176,392
ComponentAnnual stock option grant, ASC 718 grant-date fair value
Stock awards
$180,705
ComponentAnnual restricted stock unit grant, ASC 718 grant-date fair value
Total
$399,024

Also at Acadia Pharmaceuticals Inc.

Related

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.